Activation of STAT3 and key inflammatory molecules such as nuclear factor kappa-B (NF-κB) induces COX-2 expression which in turn produces prostaglandins, resulting in upregulation of proinflammatory processes that enhance breast carcinogenesis [45], [46]. The gene discussed is STAT3; the disease is medical procedure.